Jung, Jaehoon Jeong, Yujin Xu, Yinglan Yi, Joonyeop Kim, Minyoung Jeong, Hee-Jin Shin, Sang Hoon Yang, Yung-Hun Son, Junghyun Sung, Changmin 2024-01-19T08:30:48Z 2024-01-19T08:30:48Z 2023-09-21 2023-11 1942-7603 https://pubs.kist.re.kr/handle/201004/113146 Due to athletes' misuse of recombinant human growth hormone (rhGH) for performance improvement, the World Anti-Doping Agency has designated rhGH as a prohibited substance. This study focuses on the development and improvement of a simple and fast rhGH detection method using a fluorescence-incorporated antibody sensor "Quenchbody (Q-body)" that activates upon antigen binding. Camelid-derived nanobodies were used to produce stable Q-bodies that withstand high temperatures and pH levels. Notably, pituitary human growth hormone (phGH) comprises two major isoforms, namely 22 and 20 kDa GH, which exist in a specific ratio, and the rhGH variant shares the same sequence as the 22 kDa GH isoform. Therefore, we aimed to discriminate rhGH abuse by analyzing its specific isoform ratio. Two nanobodies, NbPit (recognizing phGH) and NbRec (preferentially recognizing 22 kDa rhGH), were used to develop the Q-bodies. Nanobody production in Escherichia coli involved the utilization of a vector containing 6xHis-tag, and Q-bodies were obtained using a maleimide-thiol reaction between the N-terminal of the cysteine tag and a fluorescent dye. The addition of tryptophan residue through antibody engineering resulted in increased fluorescence intensity (FI) (from 2.58-fold to 3.04-fold). The limit of detection (LOD) was determined using a fluorescence response, with TAMRA-labeled NbRec successfully detecting 6.38 ng/ml of 22 kDa rhGH while unable to detect 20 kDa GH. However, ATTO520-labeled NbPit detected 7.00 ng/ml of 20 kDa GH and 2.20 ng/ml 22 kDa rhGH. Q-bodies successfully detected changes in the GH concentration ratio from 10 to 40 ng/ml in human serum within 10 min without requiring specialized equipment and kits. Overall, these findings have potential applications in the field of anti-doping measures and can contribute to improved monitoring and enforcement of rhGH misuse, ultimately enhancing fairness and integrity in competitive sports. Nanobody-based quenchbodies are fast and simple biosensors for detecting growth hormone (GH) and its isoform. 22 kDa and 20 kDa human growth hormone could be calculated and determined within 10 min by measuring the ratio of fluorescence signals measured by two quenchbodies.image English John Wiley & Sons Ltd. Production and engineering of nanobody-based quenchbody sensors for detecting recombinant human growth hormone and its isoforms Article 10.1002/dta.3562 1 Drug Testing and Analysis, v.15, no.11-12, pp.1439 - 1448 Drug Testing and Analysis 15 11-12 1439 1448 Y scie scopus 001058122400001 2-s2.0-85169788940 Biochemical Research Methods Chemistry, Analytical Pharmacology & Pharmacy Biochemistry & Molecular Biology Chemistry Pharmacology & Pharmacy Article ANTIBODY DEFICIENCY BINDING doping test human growth hormone nanobody Quenchbody site-directed mutagenesis